208 related articles for article (PubMed ID: 10434156)
1. [Psychopharmacological profile of venlafaxine].
Bourin M
Encephale; 1999 Jun; 25 Spec No 2():21-2; discussion 23-5. PubMed ID: 10434156
[TBL] [Abstract][Full Text] [Related]
2. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
Dawson LA; Nguyen HQ; Geiger A
Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine marketed as antidepressant.
Am J Hosp Pharm; 1994 Jul; 51(13):1606. PubMed ID: 7942885
[No Abstract] [Full Text] [Related]
4. Evidence of the dual mechanisms of action of venlafaxine.
Harvey AT; Rudolph RL; Preskorn SH
Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM
Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210
[TBL] [Abstract][Full Text] [Related]
6. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
8. Clarification of venlafaxine chemistry, pharmacology, and pharmacokinetics.
Albano D; Amchin J
Am J Health Syst Pharm; 1995 Jul; 52(14):1573-4. PubMed ID: 7552908
[No Abstract] [Full Text] [Related]
9. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.
Redrobe JP; Bourin M; Colombel MC; Baker GB
Psychopharmacology (Berl); 1998 Jul; 138(1):1-8. PubMed ID: 9694520
[TBL] [Abstract][Full Text] [Related]
10. Designing a new generation of antidepressant drugs.
Pinder RM
Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
[TBL] [Abstract][Full Text] [Related]
11. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
Aldosary F; Norris S; Tremblay P; James JS; Ritchie JC; Blier P
Int J Neuropsychopharmacol; 2022 Apr; 25(4):283-292. PubMed ID: 34958348
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
Augustin BG; Cold JA; Jann MW
Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
[TBL] [Abstract][Full Text] [Related]
13. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
Dhir A; Kulkarni SK
Pharmacology; 2007; 80(4):239-43. PubMed ID: 17622775
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
15. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
[TBL] [Abstract][Full Text] [Related]
16. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
Béïque JC; de Montigny C; Blier P; Debonnel G
Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
[TBL] [Abstract][Full Text] [Related]
17. Effects of venlafaxine in the sleep architecture of rats.
Salin-Pascual RJ; Moro-Lopez ML
Psychopharmacology (Berl); 1997 Feb; 129(3):295-6. PubMed ID: 9084070
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.
Marchand F; Alloui A; Pelissier T; Hernández A; Authier N; Alvarez P; Eschalier A; Ardid D
Brain Res; 2003 Aug; 980(1):117-20. PubMed ID: 12865165
[TBL] [Abstract][Full Text] [Related]
19. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
20. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
